Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,286 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial.
Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S. Nakayama M, et al. Nephrol Dial Transplant. 2010 Sep;25(9):3026-33. doi: 10.1093/ndt/gfq196. Epub 2010 Apr 12. Nephrol Dial Transplant. 2010. PMID: 20388631 Clinical Trial.
Hydrogen gas (H(2)) ameliorates oxidative and inflammatory injuries to organs in animal models. We developed an HD system using a dialysis solution with high levels of dissolved H(2) and examined the clinical effects. METHODS: Dialysis solution with H(2) (ave …
Hydrogen gas (H(2)) ameliorates oxidative and inflammatory injuries to organs in animal models. We developed an HD system using a dia …
Regression of parathyroid gland swelling by treatment with cinacalcet.
Terawaki H, Nakano H, Takeguchi F, Hasegawa T, Nakayama M, Okazaki M, Hosoya T. Terawaki H, et al. Nephrol Dial Transplant. 2009 Feb;24(2):690-1; author reply 691-2. doi: 10.1093/ndt/gfn579. Epub 2008 Nov 5. Nephrol Dial Transplant. 2009. PMID: 18987257 No abstract available.
Novel haemodialysis (HD) treatment employing molecular hydrogen (H(2))-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study.
Nakayama M, Itami N, Suzuki H, Hamada H, Yamamoto R, Tsunoda K, Osaka N, Nakano H, Maruyama Y, Kabayama S, Nakazawa R, Miyazaki M, Ito S. Nakayama M, et al. Sci Rep. 2018 Jan 10;8(1):254. doi: 10.1038/s41598-017-18537-x. Sci Rep. 2018. PMID: 29321509 Free PMC article.
Recent studies have revealed unique biological characteristics of molecular hydrogen (H(2)) as an anti-inflammatory agent. We developed a novel haemodialysis (E-HD) system delivering an H(2) (30-80 ppb)-enriched dialysis solution by water electrolysis, and conducted …
Recent studies have revealed unique biological characteristics of molecular hydrogen (H(2)) as an anti-inflammatory agent. We develop …
Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation.
Nakayama M, Itami N, Suzuki H, Hamada H, Osaka N, Yamamoto R, Tsunoda K, Nakano H, Watanabe K, Zhu WJ, Maruyama Y, Terawaki H, Kabayama S, Nakazawa R, Miyazaki M, Ito S. Nakayama M, et al. PLoS One. 2017 Sep 13;12(9):e0184535. doi: 10.1371/journal.pone.0184535. eCollection 2017. PLoS One. 2017. PMID: 28902900 Free PMC article. Clinical Trial.
Biological effects of electrolyzed water in hemodialysis.
Nakayama M, Kabayama S, Nakano H, Zhu WJ, Terawaki H, Nakayama K, Katoh K, Satoh T, Ito S. Nakayama M, et al. Nephron Clin Pract. 2009;112(1):c9-15. doi: 10.1159/000210569. Epub 2009 Apr 3. Nephron Clin Pract. 2009. PMID: 19342864 Clinical Trial.
Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B. Maruyama Y, et al. Nephrol Dial Transplant. 2007 May;22(5):1407-12. doi: 10.1093/ndt/gfl789. Epub 2007 Jan 29. Nephrol Dial Transplant. 2007. PMID: 17264097 Clinical Trial.
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K, Tanaka M, Hashiguchi J, Funakoshi S, Nakano H, Kubo H, Kono T, Uchino J, Masaki K, Date T, Shigematsu T; Research Group for Future Hemodialysis. Itoh K, et al. Ther Apher Dial. 2008 Apr;12(2):126-32. doi: 10.1111/j.1744-9987.2008.00557.x. Ther Apher Dial. 2008. PMID: 18387160 Clinical Trial.
3,286 results
Jump to page
Feedback